Dominant mutations of hepatitis B virus variants in hepatoma accumulate in B-cell and T-cell epitopes of the HBx antigen

Virus Research

Volumn 92, Issue 2, 2003, Pages 157-164

  Hwang, Guang Yuh ^a   Huang, Chao Jun ^a   Lin, Chuang Yu ^a   Wu, Cheng Chung ^b  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Epitope; Hepatitis B virus X gene; Human hepatocellular carcinoma; Immunoevasion; Variants

Indexed keywords

EPITOPE; HEPATITIS B ANTIGEN; HEPATITIS BX ANTIGEN; PROLINE; SERINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA VECTOR; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MOLECULAR CLONING; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; SEROTYPE; VIRUS ISOLATION;

HEPATITIS B VIRUS;

EID: 0037383336     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(03)00043-1     Document Type: Article

References (48)

1. Beasley R.P. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer. 61:1988;1942-1956.
2. Brechot C. Hepatitis B virus (HBV) and hepatocellular carcinoma: HBV-DNA status and its implications. J. Hepatol. 4:1987;269-279.
3. Caselmann W.H. Transactivation of cellular gene expression by hepatitis B viral protein: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol. 22:1995;34-37.
4. Chen H.S., Kaneko S., Girones R., Anderson R.W., Hornbuckle W.E., Tennant B.C., Cote P.J., Gerin J.L., Purcell R.H., Miller R.H. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1993;1218-1226.
5. Chung M.K., Yoon H., Min S.S., Lee H.G., Kim Y.J., Lee T.G., Lim J.S., Kim C.M., Park S.N. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen. J. Immunother. 22:1999;279-287.
6. Diamantis I.D., McGandy C.E., Chen T.J., Liaw Y.F., Gudat F., Bianchi L. Hepatitis B X gene expression in hepatocellular carcinoma. J. Hepatol. 15:1992;400-403.
7. Feitelson M.A., Duan L.X., Guo J., Sun B., Woo J., Steensma K., Horiike N., Blumberg B.S. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J. Infect. Dis. 172:1995;713-722.
8. Fourel G., Trepo C., Bougueleret L., Henglein B., Ponzetto A., Tiollais P., Buendia M.A. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature. 347:1990;294-298.
9. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature. 281:1979;646-650.
10. Hollinger F.B. Hepatitis B virus. Field B.N. Virology. 1990;2171-2236 Raven Press, New York.
11. Hosono S., Tai P.C., Wang W., Ambrose M., Hwang D.G., Yaun T.T., Peng B.H., Yang C.S., Lee C.S., Shih C. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology. 212:1995;151-162.
12. Jung M.C., Stemler M., Weimer T., Spengler U., Dohrmann J., Hoffmann R., Eichenlaub D., Eisenburg J., Paumgartner G., Riethmuller G. Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus. Hepatology. 13:1991;637-643.
13. Kasai Y., Takeda S., Takagi H. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis. Semin. Surg. Oncol. 12:1996;155-156.
14. Kekule A.S., Lauer U., Weiss L., Luber B., Hofschneider P.H. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature. 361:1993;742-745.
15. Kim C.M., Koike K., Saito I., Miyamura T., Gilbert J. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (London). 351:1991;317-320.
16. Kim H., Lee H., Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273:1998;381-385.
17. Koike K., Takada S. Biochemistry and functions of hepatitis B virus X protein. Intervirology. 38:1995;89-99.
18. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamcna T., Kvrokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:1994;810-819.
19. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94:1994;44-49.
20. Lin Y., Tang H., Nomura T., Dorjsuren D., Hayashi N., Wei W., Ohta T., Roeder R., Murakami S. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J. Biol. Chem. 273:1998;27097-27103.
21. Menzo S., Clementi M., Alfani E., Bagnarelli P., Iacovacci S., Manzin A., Dandri M., Natoli G., Levreo M., Carloni G. Transactivation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology. 196:1993;878-882.
22. Milich D.R., Jones J.E., Hughes J.L., Price J., Raney A.K., McLanchlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero. Proc. Natl. Acad. Sci. USA. 87:1990;6599-6603.
23. Miller R.H., Robinson W.S. Common evolutionary origin of hepatitis B virus and retroviruses. Proc. Natl. Acad. Sci. USA. 83:1986;2531-2535.
24. Murakami S., Cheong J.H., Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J. Biol. Chem. 269:1994;15118-15123.
25. Nakatake H., Chisaka O., Yamamoto S., Matsubara K., Koshy R. Effect of X protein on Transactivation of Hepatitis B virus promoters and on viral replication. Virology. 195:1993;305-314.
26. Park O.Y., Jin Y.H., Lee M., Shin H.J., Kim H.I., Cho H., Yun C.W., Youn J.K., Park S. Characterization and gene cloning of monoclonal antibody specific for the hepatitis B virus X protein. Hybridoma. 19:2000;73-80.
27. Petzold D.R., Tautz B., Wolf F., Drescher J. Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially. J. Med. Virol. 58:1999;1-10.
28. Renner M., Haniel A., Burgelt E., Hofschneider P.H., Koch W. Transactivating function and expression of the X gene of hepatitis B virus. J. Hepatol. 23:1995;53-65.
29. Rossner M.T. Review: hepatitis B virus X gene product: a promiscuous transcriptional activator. J. Med. Virol. 36:1992;101-117.
30. Seto E., Mitchell P.J., Yen T.S. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (London). 344:1990;72-74.
31. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80:1989;617-621.
32. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 18:1999;4848-4859.
33. Spandau D.F., Lee C.H. Trans activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62:1988;427-434.
34. Stemler M., Weimer T., Tu Z.X., Wan D.F., Levrero M., Jung C., Pape G.R., Will H. Mapping of B-cell epitopes of the human hepatitis B virus X protein. J. Virol. 64:1990;2802-2809.
35. Sung J.L., Chen D.S. Clustering of different subtypes of hepatitis B surface antigen in families of patients with chronic liver diseases. Am. J. Gastroenterol. 69:1978;559-564.
36. Tai P.C., Banik D., Lin G.I., Pai S., Pai K., Lin M.H., Yuoh G., Che S., Hsu S.H., Chen T.C., Kuo T.T., Lee C.S., Yang C.S., Shih C. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J. Virol. 71:1997;4852-4856.
37. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 317:1985;489-495.
38. Twu J.S., Chu K., Robinson W.S. Hepatitis B virus X gene activates kB-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA. 86:1989;5168-5172.
39. Twu J.S., Lai M.Y., Chen D.H., Robinson W.S. Activation of protooncogene C-Jun by the X protein of hepatitis B virus. Viroloy. 192:1993;346-350.
40. Wang J., Chenivesse C.X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 343:1990;555-557.
41. Wang W., London W.T., Feitelson M.A. Hepatitis B X antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 51:1991;4971-4977.
42. Yen T.S.B. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci. 3:1996;20-30.
43. Yeh C.T., Shen C.H., Tai D.I., Chu C.M., Liaw Y.F. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene. 19:2000;5213-5220.
44. Zahm P., Hofschneider P.H., Koshy R. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene. 3:1988;169-177.
45. Zentgraf H., Herrmann G., Klein R., Schranz P., Loncarevic I., Herrmann D., Hubner K., Schroder C.H. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology. 47:1990;143-148.
46. Zhu M., London W.T., Duan L.X., Feitelson M.A. The value of hepatitis B X antigen as a prognostic marker in the development of hepatocellular carcinoma. Int. J. Cancer. 55:1993;571-576.
47. Zinkernagel R.M., Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lympholytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 248:1974;701-702.
48. Zoulim F., Saputelli J., Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:1994;2026-2030.